General MedicationsBUCCALStandard
ORAVIG
MICONAZOLE
Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ORAVIG is listed in Drugs@FDA under application 022404 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MICONAZOLE Form and strength TABLET;BUCCAL - 50MG Sponsor GALT PHARMS Submission history Latest submission status date: 2020-02-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview ORAVIG is listed in Drugs@FDA under application 022404 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MICONAZOLE Form and strength TABLET;BUCCAL - 50MG Sponsor GALT PHARMS Submission history Latest submission status date: 2020-02-04 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.